ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Eloxx Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$12.50−0.53 (-4.07%)
Close on Oct 19, 2026
- Market cap
- $84.86M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 31, 2023(first seen in filings) | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |
| Nov 14, 2013(first seen in filings) | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |